Setup for human sera MALDI profiling

The case of rhEPO treatment

Chiara Fania, Michele Vasso, Enrica Torretta, Paul Robach, Gaetano Cairo, Carsten Lundby, Cecilia Gelfi

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The implementation of high-throughput technologies based on qualitative and quantitative methodologies for the characterization of complex protein mixtures is increasingly required in clinical laboratories. MALDI profiling is a robust and sensitive technology although the serum high dynamic range imposes a major limitation hampering the identification of less abundant species decreasing the quality of MALDI profiling. A setup to improve these parameters has been performed for recombinant human erythropoietin (rhEPO) monitoring in serum, analyzing the effects of two commercially available columns (MARS Hu7 and Hu14) for immunodepletion, and two matrices (α-cyano-4-hydroxycinnamic acid and 2',4'-dihydroxyacetophenone) for peak quality improvement. The immunodepletion capability of both columns was determined by 2-D DIGE, which precisely revealed the efficacy of Hu14 in protein removal and the serum dynamic range decrement. In addition, the type of matrix, the sample dilution, and the efficacy of optimized parameters were used for serum profiling of ten healthy subjects before and after rhEPO treatment. The principal component analysis indicates that a combination of Hu14 column and 2',4'-dihydroxyacetophenone matrix increases data quality allowing the discrimination between treated and untreated samples, making serum MALDI profiling suitable for clinical monitoring of rhEPO.

Original languageEnglish
Pages (from-to)1715-1727
Number of pages13
JournalElectrophoresis
Volume32
Issue number13
DOIs
Publication statusPublished - Jun 2011

Fingerprint

Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry
Erythropoietin
Serum
Clinical laboratories
Monitoring
Technology
Principal component analysis
Dilution
Proteins
Therapeutics
Quality Improvement
Principal Component Analysis
Complex Mixtures
Throughput
Blood Proteins
Healthy Volunteers
2,4-dihydroxyacetophenone

Keywords

  • 2-D differential gel electrophoresis
  • EPO
  • Immunodepletion
  • MALDI profiling
  • Serum

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry

Cite this

Fania, C., Vasso, M., Torretta, E., Robach, P., Cairo, G., Lundby, C., & Gelfi, C. (2011). Setup for human sera MALDI profiling: The case of rhEPO treatment. Electrophoresis, 32(13), 1715-1727. https://doi.org/10.1002/elps.201100134

Setup for human sera MALDI profiling : The case of rhEPO treatment. / Fania, Chiara; Vasso, Michele; Torretta, Enrica; Robach, Paul; Cairo, Gaetano; Lundby, Carsten; Gelfi, Cecilia.

In: Electrophoresis, Vol. 32, No. 13, 06.2011, p. 1715-1727.

Research output: Contribution to journalArticle

Fania, C, Vasso, M, Torretta, E, Robach, P, Cairo, G, Lundby, C & Gelfi, C 2011, 'Setup for human sera MALDI profiling: The case of rhEPO treatment', Electrophoresis, vol. 32, no. 13, pp. 1715-1727. https://doi.org/10.1002/elps.201100134
Fania C, Vasso M, Torretta E, Robach P, Cairo G, Lundby C et al. Setup for human sera MALDI profiling: The case of rhEPO treatment. Electrophoresis. 2011 Jun;32(13):1715-1727. https://doi.org/10.1002/elps.201100134
Fania, Chiara ; Vasso, Michele ; Torretta, Enrica ; Robach, Paul ; Cairo, Gaetano ; Lundby, Carsten ; Gelfi, Cecilia. / Setup for human sera MALDI profiling : The case of rhEPO treatment. In: Electrophoresis. 2011 ; Vol. 32, No. 13. pp. 1715-1727.
@article{3a7673859dee4fed90bb1f51655296b7,
title = "Setup for human sera MALDI profiling: The case of rhEPO treatment",
abstract = "The implementation of high-throughput technologies based on qualitative and quantitative methodologies for the characterization of complex protein mixtures is increasingly required in clinical laboratories. MALDI profiling is a robust and sensitive technology although the serum high dynamic range imposes a major limitation hampering the identification of less abundant species decreasing the quality of MALDI profiling. A setup to improve these parameters has been performed for recombinant human erythropoietin (rhEPO) monitoring in serum, analyzing the effects of two commercially available columns (MARS Hu7 and Hu14) for immunodepletion, and two matrices (α-cyano-4-hydroxycinnamic acid and 2',4'-dihydroxyacetophenone) for peak quality improvement. The immunodepletion capability of both columns was determined by 2-D DIGE, which precisely revealed the efficacy of Hu14 in protein removal and the serum dynamic range decrement. In addition, the type of matrix, the sample dilution, and the efficacy of optimized parameters were used for serum profiling of ten healthy subjects before and after rhEPO treatment. The principal component analysis indicates that a combination of Hu14 column and 2',4'-dihydroxyacetophenone matrix increases data quality allowing the discrimination between treated and untreated samples, making serum MALDI profiling suitable for clinical monitoring of rhEPO.",
keywords = "2-D differential gel electrophoresis, EPO, Immunodepletion, MALDI profiling, Serum",
author = "Chiara Fania and Michele Vasso and Enrica Torretta and Paul Robach and Gaetano Cairo and Carsten Lundby and Cecilia Gelfi",
year = "2011",
month = "6",
doi = "10.1002/elps.201100134",
language = "English",
volume = "32",
pages = "1715--1727",
journal = "Electrophoresis",
issn = "0173-0835",
publisher = "Wiley-VCH Verlag",
number = "13",

}

TY - JOUR

T1 - Setup for human sera MALDI profiling

T2 - The case of rhEPO treatment

AU - Fania, Chiara

AU - Vasso, Michele

AU - Torretta, Enrica

AU - Robach, Paul

AU - Cairo, Gaetano

AU - Lundby, Carsten

AU - Gelfi, Cecilia

PY - 2011/6

Y1 - 2011/6

N2 - The implementation of high-throughput technologies based on qualitative and quantitative methodologies for the characterization of complex protein mixtures is increasingly required in clinical laboratories. MALDI profiling is a robust and sensitive technology although the serum high dynamic range imposes a major limitation hampering the identification of less abundant species decreasing the quality of MALDI profiling. A setup to improve these parameters has been performed for recombinant human erythropoietin (rhEPO) monitoring in serum, analyzing the effects of two commercially available columns (MARS Hu7 and Hu14) for immunodepletion, and two matrices (α-cyano-4-hydroxycinnamic acid and 2',4'-dihydroxyacetophenone) for peak quality improvement. The immunodepletion capability of both columns was determined by 2-D DIGE, which precisely revealed the efficacy of Hu14 in protein removal and the serum dynamic range decrement. In addition, the type of matrix, the sample dilution, and the efficacy of optimized parameters were used for serum profiling of ten healthy subjects before and after rhEPO treatment. The principal component analysis indicates that a combination of Hu14 column and 2',4'-dihydroxyacetophenone matrix increases data quality allowing the discrimination between treated and untreated samples, making serum MALDI profiling suitable for clinical monitoring of rhEPO.

AB - The implementation of high-throughput technologies based on qualitative and quantitative methodologies for the characterization of complex protein mixtures is increasingly required in clinical laboratories. MALDI profiling is a robust and sensitive technology although the serum high dynamic range imposes a major limitation hampering the identification of less abundant species decreasing the quality of MALDI profiling. A setup to improve these parameters has been performed for recombinant human erythropoietin (rhEPO) monitoring in serum, analyzing the effects of two commercially available columns (MARS Hu7 and Hu14) for immunodepletion, and two matrices (α-cyano-4-hydroxycinnamic acid and 2',4'-dihydroxyacetophenone) for peak quality improvement. The immunodepletion capability of both columns was determined by 2-D DIGE, which precisely revealed the efficacy of Hu14 in protein removal and the serum dynamic range decrement. In addition, the type of matrix, the sample dilution, and the efficacy of optimized parameters were used for serum profiling of ten healthy subjects before and after rhEPO treatment. The principal component analysis indicates that a combination of Hu14 column and 2',4'-dihydroxyacetophenone matrix increases data quality allowing the discrimination between treated and untreated samples, making serum MALDI profiling suitable for clinical monitoring of rhEPO.

KW - 2-D differential gel electrophoresis

KW - EPO

KW - Immunodepletion

KW - MALDI profiling

KW - Serum

UR - http://www.scopus.com/inward/record.url?scp=79959717425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959717425&partnerID=8YFLogxK

U2 - 10.1002/elps.201100134

DO - 10.1002/elps.201100134

M3 - Article

VL - 32

SP - 1715

EP - 1727

JO - Electrophoresis

JF - Electrophoresis

SN - 0173-0835

IS - 13

ER -